HRTIS — Herantis Pharma Oyj Cashflow Statement
0.000.00%
Last trade - 00:00- €34.88m
- €28.42m
Annual cashflow statement for Herantis Pharma Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8 | -9.15 | -12.8 | -9.32 | 0.28 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.85 | 1.08 | 0.308 | 1.33 | -4.58 |
| Extraordinary Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.15 | -1.42 | -0.195 | -1.11 | -0.335 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.96 | -8.56 | -9.93 | -8.94 | -4.64 |
| Other Investing Cash Flow Items | 0 | 0.004 | 0 | -0.21 | 0.607 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0.004 | 0 | -0.21 | 0.607 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.8 | 14.9 | 4.03 | 8.56 | 4.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.81 | 6.33 | -5.9 | -0.595 | 0.467 |